{"id":2678,"date":"2015-01-05T22:25:00","date_gmt":"2015-01-05T22:25:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2678"},"modified":"2025-01-16T15:36:34","modified_gmt":"2025-01-16T15:36:34","slug":"forecasting-the-disease-burden-of-chronic-hepatitis-c-virus-in-poland","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/forecasting-the-disease-burden-of-chronic-hepatitis-c-virus-in-poland\/","title":{"rendered":"Pr\u00e9vision de la charge de morbidit\u00e9 du virus de l&#039;h\u00e9patite C chronique en Pologne"},"content":{"rendered":"<h2 class=\"wp-block-heading\">R\u00e9sum\u00e9<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Contexte et objectifs<\/h3>\n\n\n\n<p>L&#039;infection chronique par le virus de l&#039;h\u00e9patite C est r\u00e9pandue chez 200 000 personnes en Pologne; cependant, peu sont au courant de leur \u00e9tat (30 000 diagnostiqu\u00e9s) et encore moins sont trait\u00e9s (2 490 en 2014). Cette analyse a projet\u00e9 la charge de morbidit\u00e9 future et d\u00e9velopp\u00e9 deux sc\u00e9narios de traitement pour contr\u00f4ler ou \u00e9liminer les maladies li\u00e9es au virus de l&#039;h\u00e9patite C en Pologne.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">M\u00e9thodes<\/h3>\n\n\n\n<p>En utilisant une approche de mod\u00e9lisation, la population infect\u00e9e et la progression future de la maladie ont \u00e9t\u00e9 quantifi\u00e9es. Les variables de base comprenaient la pr\u00e9valence vir\u00e9mique, l&#039;\u00e2ge et le sexe, le taux de diagnostic, le taux de traitement, la progression de la maladie et les taux de r\u00e9ponse virologique soutenus. Les donn\u00e9es ont \u00e9t\u00e9 collect\u00e9es \u00e0 partir de la litt\u00e9rature et gr\u00e2ce \u00e0 des entretiens d&#039;experts.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">R\u00e9sultats<\/h3>\n\n\n\n<p>Le nombre d&#039;infections \u00e0 virus de l&#039;h\u00e9patite C pr\u00e9valentes devrait diminuer (5%) d&#039;ici 2030. Cependant, on estime que le nombre de personnes atteintes de cirrhose compens\u00e9e et d\u00e9compens\u00e9e et de carcinome h\u00e9patocellulaire augmentera de 40, 55 et 60%, respectivement. En augmentant les taux de r\u00e9ponse virologique soutenue \u00e0 95% \u00e0 partir de 2015 et le nombre de cas trait\u00e9s (de 2490 \u00e0 5000), le nombre de personnes atteintes de cirrhose, de cirrhose d\u00e9compens\u00e9e et de carcinome h\u00e9patocellulaire devrait rester constant jusqu&#039;en 2030. Une strat\u00e9gie pour \u00e9liminer l&#039;infection chronique par le virus de l&#039;h\u00e9patite C a \u00e9galement \u00e9t\u00e9 envisag\u00e9e. Pour r\u00e9duire les infections totales de 90% et la mortalit\u00e9 de 80%, le traitement a \u00e9t\u00e9 augment\u00e9 \u00e0 15 000 patients par an. Ce sc\u00e9nario a n\u00e9cessit\u00e9 le diagnostic de 15 000 nouveaux cas (contre 3 000 aujourd&#039;hui).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Conclusion<\/h3>\n\n\n\n<p>Une r\u00e9duction marqu\u00e9e de la charge de morbidit\u00e9 li\u00e9e au virus de l&#039;h\u00e9patite C est possible, avec un diagnostic et un traitement accrus. Les r\u00e9sultats pourraient \u00e9clairer le d\u00e9veloppement d&#039;une gestion efficace de la maladie en Pologne.<\/p>\n\n\n\n<p><strong>Des pays:<\/strong> Pologne<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25426979\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary Background and Aims Chronic hepatitis C virus infection is prevalent among 200,000 individuals in Poland; however, few are aware of their condition (30,000 diagnosed) and even fewer are treated (2490 in 2014). This analysis projected future disease burden and developed two treatment scenarios to control or eliminate hepatitis C virus-related disease in Poland. Methods [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3306,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[10],"publication-author":[2104,2107,2106,2103,1118,2105],"class_list":["post-2678","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-hcv","publication-author-flisiak-r","publication-author-gower-ee","publication-author-halota-w","publication-author-kostrzewska-k","publication-author-razavi-ha","publication-author-tomasiewicz-k"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2678"}],"version-history":[{"count":6,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2678\/revisions"}],"predecessor-version":[{"id":7611,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2678\/revisions\/7611"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3306"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2678"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}